Non-Myeloablative Stem Cell Transplantation in Hematologic Malig¬nancies: An Experience from the Hematology-Oncology and BMT Re¬search Center

: Myeloablative-allogeneic stem cell transplantation is a common way of treating various malignant and nonma-lignant diseases; but, it is associated with hazardous immediate and late complications. The majority of patients are not good candidates for high dose therapy because of old age, medical co-...

Full description

Bibliographic Details
Main Authors: Keyhanian S, Ghavamzadeh A, Bahar B, Alimoghaddam K, Shamshiri AR, Gholibeikian.S
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2004-08-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/4492.pdf&manuscript_id=4492